Considering an M&A Early Exit for your medtech startup?
Finish Strong & Exit On Your Terms, Not Your Runway
Welcome to MedtechManda.com, your trusted partner in navigating early exits for medical device startups. In today's challenging landscape, with VC funding down 30%, timing is everything. We ensure you're ready to seize opportunity, optimize value and finish on your very best terms.
We might just be your ideal early exit solution
Early exits allow you to capitalize on market trends, reduce risk, and maximize returns while you still hold a unique, competitive edge in your market. But expert help has been hard to find - traditional M&A pros don't take on <$25M deals and broker services are too generic - until now.
Cost Effective
Our flat fee structure is 4-6x cheaper than traditional broker retainers and success fees.
Research Based
Your exit is too critical for cookie cutter MOs. Success demands deep intel and bespoke strategies.
Founder-Centric
Retain control and drive your company to success while leveraging our expertise.
Rapid Results
Accelerate your path to LOI with our proven strategies to attract buyers and achieve your best deal terms.
Expert Support
Exits are endurance events. We're with you at every step to navigate hurdles and cross the finish line.
Small Ball Strategies In Your Inbox
'Small ball' strategies are efficient, tactical initiatives to prepare for, attract, and secure durable deals. This weekly newsletter includes strategies, tactics, and tips to help you lead your medical device startup or SMB to a successful and durable equity/asset sale or partnership
If the following describes youwe're a perfect match
Our ideal clients are medtech startups and SMBs that often fall outside the typical target profile. Pre-commercial (even pre-regulatory clearance) Class I/II medical and assistive devices are our sweet spot for transformative ROIs.
Lower-middle market (aka 'small ball'); < $25M anticipated deal value, upfront cash & earn-outs inclusive.
FDA/Health Canada Class I or II devices at the Proof of Concept stage or later are a strong fit.
Industry standard process, documentation & patents are sellable intellectual properties.
A privately held, clear cap table with shareholders on board and a dedicated deal lead or point person.
Flexible services that empower you to execute a flawless exit
Our service packages handle all the heavy lifting — research, strategy, and preparation — so you are perfectly positioned to lead your most successful early exit
Featured Service
Early Exit Roadmap to Premium Acquirers & Valuation
Uncover Hidden Acquirers and Maximize Your Medtech Valuation
Think you know all your potential buyers? Think again. Our Buyer Landscape Analysis goes beyond the obvious to uncover hidden gems in the medtech M&A market, providing you with powerful insights to attract your ideal acquirers and maximize your valuation.
Key Benefits:
Discover at least 5 potential acquirers you haven't considered
Understand what truly drives acquirer interest in your medtech segment
Gain insider knowledge on how to position your company for maximum valuation
Develop a targeted strategy to attract and engage ideal buyers
Identify key value drivers that can significantly boost your exit potential
Process:
Initial consultation to understand your technology and goals
Comprehensive market research and data analysis
Expert evaluation of potential strategic and financial buyers
Development of a tailored report with actionable insights
Strategy session to discuss findings and next steps
Deliverables:
Comprehensive Buyer Landscape Report with hidden gem acquirers
Acquirer Interest Matrix: Map your technology to buyer motivations
Valuation Enhancement Roadmap
Targeted Buyer Engagement Strategies
90-minute Strategy Session with Our M&A Experts
Investment: $2,500 USD
Timeline: 2 weeks
Don't leave money on the table. Uncover hidden acquirers and maximize your valuation today
Pre-Exit Feasibility: Know Your Worth
Arm yourself with critical insights before entering the M&A arena. Our Pre-Exit feasibility study provides a 360-degree view of your company's exit readiness.
Detailed company valuation report
Market positioning analysis
Regulatory compliance assessment
Potential acquirer shortlist
Timeline: 4-6 weeksMake data-driven decisions about your exit strategy with confidence.
"Exit in a Box" Kit: Your DIY Exit Toolkit
Empower your team with our comprehensive "Exit in a Box" Kit. Everything you need to prepare for a successful exit, right at your fingertips.
Customized exit strategy playbook
Due diligence data room setup guide
Buyer prospectus template
2-hour strategy call with M&A advisor
Timeline: Kit 2 weeks+ 1 month supportTake control of your exit journey with expert-designed tools and guidance.
Deal Lead in a Box: Your M&A Sherpa
Navigate the complex terrain of medtech exits with our comprehensive "Deal Lead in a Box" service. Perfect for startups lacking in-house M&A expertise.
Comprehensive deal strategy document
Due diligence management toolkit
Weekly progress reports
Negotiation playbook, valuation analysis
Post-deal integration roadmap
Timeline: 3-6 MonthsMaximize your exit potential with expert guidance every step of the way.
"Fast Track" Exit: Beat the Clock
For companies with less than 6 months of runway, our Fast Track Exit provides intensive support to optimize and accelerate your exit process.
Rapid valuation assessment
Emergency funding options analysis
Accelerated buyer outreach strategy
Weekly advisory calls
Crisis communication plan
Timeline: 8-12 weeks intensive supportTurn time pressure into an advantage with our rapid-response approach.
"Exit Sprint": 30 Days to Exit Readiness
Supercharge your exit preparation with our intensive 30-day program. Ideal for companies needing to move quickly in a competitive market.
Daily advisor check-ins
Rapid due diligence preparation
Accelerated buyer identification and outreach
Deal negotiation support
Timeline: 30 DaysTransform your exit timeline from months to weeks with our high-intensity approach.
À La Carte M&A Modules for Medtech Startups
Unlock your medtech company's exit potential with our flexible, tailored M&A solutions. Our à la carte modules offer targeted expertise to propel your strategic growth.
Prospectus Draft: Showcase Your Value
- Craft a compelling narrative of your company's unique value
- Highlight growth potential to attract top-tier acquirers
- Position your medtech innovation for maximum market impactBuyer Intel Deep Dive: Know Your Market
- Gain critical insights into potential acquirers
- Understand strategic priorities driving M&A in medtech
- Align your offering with key acquisition criteriaWhy Choose Our À La Carte Approach?
1. Cost-Effective: Address critical M&A needs without breaking the bank
2. Strategic Foundation: Build a solid base for future exit opportunities
3. Informed Decision-Making: Gain valuable market insights to guide your strategyPerfect for resource-conscious medtech founders and CEOs, our modular services provide a smart start to your exit journey. Begin preparing for strategic partnerships or acquisitions today, without committing to a full M&A package.Ready to take the next step in your medtech M&A strategy? Contact us now to tailor your à la carte solution.
The Success Story I get asked about the most
Every medtech exit is unique and represents an epic saga of near loss and final saves. People love a good 'triumph against all odds story' and the following has that in spades. Check it out and see what's possible.
Amanda Cooper
Over the last 15 years, I've brought my experience and education in medical device development, mergers & acquisitions, strategic engagement, and negotiation to bear for startup medical device developers across Canada and the US.I choose to focus on assisting medtech startups to achieve early exits through acquisition and partnerships because the courage, dedication and investment required to develop an innovative medical device should never be for naught.
The early exit resources you need to succeed
A collection of tools and tips developed specifically for medical device startup and SMB leaders to execute an exit and finish strong (more coming soon!)
Click to access our Medical Device M&A Resource Library
Your corporate legacy is in your hands
Medtech success can be ambiguous and elusive; your commitment to choosing the correct course and finishing strong should be anything but. If your version of success looks like an early exit through acquisition by an organization better positioned to market your technology, we'd like to help.
© AE Cooper Medical Ventures. All rights reserved.